AI assistant
Sending…
ATAI Life Sciences N.V. — Director's Dealing 2021
Jun 22, 2021
32049_dirs_2021-06-22_fff36dc2-95d5-482f-ad83-3577923f6ded.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ATAI Life Sciences N.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-06-17
Reporting Person: WEAVER GREGORY L (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-17 | Stock Option | $15.00 | A | 67726 | Acquired | 2031-06-17 | Common Shares (67726) | Direct |
Footnotes
F1: The stock option vests as to 25% of the underlying shares on June 17, 2022, and the remaining vests in 36 equal monthly installments thereafter.
More from ATAI Life Sciences N.V.
Regulatory Filings
2026
Mar 20
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Nov 26
Interim / Quarterly Report
2025
Nov 12
Earnings Release
2025
Nov 12
Director's Dealing
2025
Nov 7